AbCellera Biologics Inc. - Ordinary Shares (ABCL) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q4 2025

Type / Class
Equity / Ordinary Shares
Symbol
ABCL on Nasdaq
Shares outstanding
293,061,432
Price per share
$3.86
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
108,113,334
Total reported value
$369,573,317
% of total 13F portfolios
0%
Share change
+3,833,772
Value change
-$11,116,504
Number of holders
142
Price from insider filings
$3.86
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AbCellera Biologics Inc. - Ordinary Shares (ABCL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BAILLIE GIFFORD & CO 4.4% $32,881,493 12,894,703 BAILLIE GIFFORD & CO 30 Sep 2024

As of 31 Dec 2025, 142 institutional investors reported holding 108,113,334 shares of AbCellera Biologics Inc. - Ordinary Shares (ABCL). This represents 37% of the company’s total 293,061,432 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of AbCellera Biologics Inc. - Ordinary Shares (ABCL) together control 34% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BAKER BROS. ADVISORS LP 9.4% 27,525,640 0% 0.55% $94,137,689
Capital World Investors 4.6% 13,361,096 0% 0.01% $45,694,948
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 2.7% 7,876,629 0.01% $26,938,071
TWO SIGMA INVESTMENTS, LP 2% 5,810,985 +12% 0.03% $19,873,569
TWO SIGMA ADVISERS, LP 1.7% 4,878,000 +1.6% 0.03% $16,682,760
GOLDMAN SACHS GROUP INC 1.5% 4,344,485 +1636% 0% $14,858,139
ArrowMark Colorado Holdings LLC 1.4% 4,105,095 0% 0.31% $14,039,425
BlackRock, Inc. 1.3% 3,865,896 +6.2% 0% $13,221,366
Driehaus Capital Management LLC 1.3% 3,771,999 +118% 0.09% $12,900,237
MORGAN STANLEY 1% 3,001,850 +7.5% 0% $10,266,329
BANK OF AMERICA CORP /DE/ 0.9% 2,632,872 +8.9% 0% $9,004,422
RENAISSANCE TECHNOLOGIES LLC 0.82% 2,389,229 -29% 0.01% $8,171,163
UBS Group AG 0.66% 1,939,409 -22% 0% $6,632,778
CITADEL ADVISORS LLC 0.63% 1,834,508 +82% 0% $6,274,017
TUDOR INVESTMENT CORP ET AL 0.61% 1,796,010 +146% 0.03% $6,142,354
Guardian Partners Inc. 0.61% 1,786,414 0% 0.47% $5,819,229
MILLENNIUM MANAGEMENT LLC 0.61% 1,773,539 -27% 0% $6,065,503
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.52% 1,524,563 +7.5% 0.01% $5,214,005
JANE STREET GROUP, LLC 0.48% 1,397,088 +252% 0.01% $4,778,041
Point72 Asset Management, L.P. 0.33% 976,507 0.01% $3,339,654
VOLORIDGE INVESTMENT MANAGEMENT, LLC 0.24% 695,796 +170% 0.01% $2,379,622
STATE STREET CORP 0.24% 694,114 +3.4% 0% $2,373,870
HRT FINANCIAL LP 0.19% 548,431 +26% 0.01% $1,875,000
Intellectus Partners, LLC 0.18% 523,383 -3.6% 0.35% $1,789,969
STATE OF MICHIGAN RETIREMENT SYSTEM 0.14% 400,000 0% 0.01% $1,368,000

Institutional Holders of AbCellera Biologics Inc. - Ordinary Shares (ABCL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 108,113,334 $369,573,317 -$11,116,504 $3.42 142
2025 Q3 104,032,627 $524,646,193 +$3,617,959 $5.03 140
2025 Q2 107,623,463 $370,594,083 -$42,109,114 $3.43 127
2025 Q1 124,693,841 $278,605,461 +$21,793,003 $2.23 127
2024 Q4 113,909,183 $333,909,974 +$23,930,958 $2.93 145
2024 Q3 105,626,999 $274,569,746 -$27,524,912 $2.60 139
2024 Q2 114,251,365 $337,827,363 -$12,985,717 $2.96 146
2024 Q1 120,885,782 $546,343,961 +$6,435,245 $4.53 153
2023 Q4 119,177,804 $681,087,686 -$3,743,767 $5.71 141
2023 Q3 120,025,395 $551,791,208 -$29,473,838 $4.60 137
2023 Q2 124,831,655 $809,068,808 -$42,715,484 $6.46 167
2023 Q1 130,072,488 $980,706,858 +$9,956,814 $7.54 181
2022 Q4 138,959,875 $1,408,301,843 +$64,970,441 $10.13 198
2022 Q3 132,080,272 $1,309,587,378 +$125,586,082 $9.89 185
2022 Q2 117,984,795 $1,259,732,308 +$77,596,210 $10.65 160
2022 Q1 113,127,329 $1,100,172,856 -$30,931,776 $9.75 126
2021 Q4 114,533,051 $1,628,519,417 +$98,165,187 $14.30 120
2021 Q3 98,697,276 $1,977,505,786 +$155,909,310 $20.04 115
2021 Q2 90,556,840 $1,986,081,198 +$169,321,459 $22.00 111
2021 Q1 71,121,706 $2,415,006,720 +$64,105,935 $33.96 82
2020 Q4 68,103,635 $2,740,470,000 +$2,587,818,000 $40.24 58